Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2900 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Bioheart to acquire Medicalgorithmics

Under the terms of the non-binding ‘letter of intent’, both companies are expected to conduct their due diligence review within the next 60-90 days. The PocketECG, manufactured by

Sucampo names new acting CFO

Mr Smilek replaces former CFO Mariam Morris, who resigned effective August 1, 2008 and will serve as a part-time consultant to the company to assist in the management

Veridex acquires assets of Immunicon

The assets acquired include intellectual property, product inventory and clinical data as well as all technologies related to the CellSearch system, claimed to be the first diagnostic test

Astellas introduces antifungal agent Mycamine in UK

Astellas’s European subsidiary has submitted a marketing authorization application under the centralized procedure to European Medicines Agency for Mycamine in April 2006. Following the review, the European Committee